language_icon
EN
HI

Albert David Share price

ALBERTDAVD

708.35

8.10 (-1.13%)
NSE
BSE
Last updated on 20 May, 2026 | 15:31 IST
Today's High

711.65

Today's Low

704.85

52 Week Low

579.90

52 Week High

957.50

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Albert David Chart

Albert David Share Key Metrics

Volume
734.00
Market Cap
404.27 CR
LTQ@LTP
2@708.35
ATP
707.83
Var Margin
18.8 %
Circuit Range
573.2-859.7
Delivery %
65.15 %
Value
5.20 L
ASM/GSM
No
Market Lot
1

Summary

Albert David share price is ₹708.35 as of 21 May, 2026. The stock Albert David intraday movement has stayed between ₹704.85 and ₹711.65, while on a 52-week basis,Albert David price 52 week high is ₹957.50 & its 52 week low is ₹579.90.
In terms of trading activity, Albert David has recorded a volume of 734 shares, The Albert David has a market cap of ₹5707162 CR. The stock’s Average Traded Price (ATP) stands at ₹707.83, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹708.35.
Albert David operates within a circuit range of ₹573.20 – ₹859.70, with a Value of ₹5.20 L. The Delivery Percentage for the day is 65.15%. Additionally, Albert David currently falls under the No framework, and trades with a market lot size of 1.

Albert David Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

71.7

Sector P/B

3.51

Sec. Div. Yield

0.56

Albert David Resistance and Support

Pivot 714.87

Resistance

First Resistance

720.79

Second Resistance

725.12

Third Resistance

731.04

Support

First Support

710.54

Second Support

704.62

Third Support

700.29

Albert David Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

62.24%

Mutual Fund

0.01%

Insurance

1.61%

Foreign Institutional Investors

0.58%

Domestic Institutional Investors

0.04%

Retail

35.52%

Others

0%

Total Promoters
MAR '26
62.24%

Albert David Corporate Actions

DateAgenda
2026-05-12Audited Results & Final Dividend
2026-02-11Quarterly Results
2025-11-12Quarterly Results
2025-08-02Quarterly Results
2025-05-13Audited Results & Final Dividend
2025-02-12Quarterly Results

Albert David News

Albert David Limited

Albert David Limited announced the appointment of Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla, a seasoned leader with over 28 years of experience, is recognized for transforming underperforming businesses into high-growth engines across leading pharmaceutical organizations.
May 13 2026 17:05:00

Albert David Limited

Albert David Limited announced the appointment of Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla, a seasoned leader with over 28 years of experience, is recognized for transforming underperforming businesses into high-growth engines across leading pharmaceutical organizations.
May 13 2026 17:05:00

Albert David Ltd-$ - 524075 - Integrated Filing Financials For The Fourth Quarter And Year Ended 31St March 2026

Albert David announced its Q4 and full-year FY26 audited financial results. The company's net profit for FY26 turned into a loss of Rs.1.49 crore, and total income declined 9% YoY to Rs.341.05 crore. Despite the financial performance, the board recommended a final dividend of Rs.5 per share for FY26.
May 13 2026 16:05:00

Albert David Ltd-$ - 524075 - KMP''s Authorised To Determine Materiality Under Regulation 30(5) Of SEBI(LODR),2015

Albert David has appointed Mr. Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla is a seasoned leader with over 28 years of experience in the pharmaceutical sector, including stints at Cipla, Glenmark, and JB Pharma.
May 12 2026 20:05:00

Albert David Ltd-$ - 524075 - Record Date Fixed On 30Th July 2026 For The Purpose Of Final Dividend And Determining Members Eligible To Vote For 87Th AGM.

Albert David has appointed Mr. Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla is a seasoned leader with over 28 years of experience in the pharmaceutical sector, including stints at Cipla, Glenmark, and JB Pharma.
May 12 2026 20:05:00

Albert David Ltd-$ - 524075 - Re-Appointment Of Cost Auditors For The F.Y. 2026-27

Albert David has appointed Mr. Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla is a seasoned leader with over 28 years of experience in the pharmaceutical sector, including stints at Cipla, Glenmark, and JB Pharma.
May 12 2026 19:05:00

Albert David Ltd-$ - 524075 - Re-Appointment Of Internal Auditors For The F.Y. 2026-27

Albert David has appointed Mr. Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla is a seasoned leader with over 28 years of experience in the pharmaceutical sector, including stints at Cipla, Glenmark, and JB Pharma.
May 12 2026 19:05:00

Albert David Ltd-$ - 524075 - Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Albert David's Board will convene on May 12, 2026, to consider and approve the audited financial results for Q4 and the full financial year ended March 31, 2026. They will also consider recommending a final dividend.
May 04 2026 15:05:00
Read More

About Albert David

NSE : 17256  
BSE : 524075  
ISIN : INE155C01010  

Albert David Management

NamePosition
Lalit LohiaCompany Secretary & Compliance Officer
Arun Kumar KothariChairman
View More

Albert David FAQs

The Buying Price of Albert David share is 708.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Albert David stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Albert David, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Albert David shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Albert David shares is 0. Useful to assess the stock's value relative to its book value.

To assess Albert David’s valuation compare Sector P/E, P/B which are 71.7 & 3.51 with sector averages, along with growth rates and financial metrics.

The Market Cap of Albert David is 404.27 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Albert David share price is 957.50 & 579.90. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Albert David belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost